Stage IIIC Ovarian Cancer: Surgery or Chemo First?

Stage IIIC high-grade serous ovarian cancer is advanced, but treatment is still planned actively. For many patients, care involves cytoreductive surgery (CRS), also known as debulking surgery, and platinum-based chemotherapy. The main decision is whether surgery should come first or after a few cycles of chemotherapy. That choice depends on where the cancer has spread, whether complete removal appears possible, the patient’s fitness for major surgery, and the experience of the gynaecological-oncology team.

This page explains the decision in practical terms. It cannot determine which sequence is right for an individual patient; that requires review of scans, biopsy results, blood tests and overall health by a multidisciplinary cancer team.

What does Stage IIIC ovarian cancer mean for me?

High-grade serous carcinoma is the most common aggressive form of epithelial ovarian cancer. It can also arise from the fallopian tube or peritoneum and is treated in a similar way. “Stage IIIC” means cancer has spread beyond the pelvis to the abdominal lining or structures and/or to certain lymph nodes. The exact pattern differs from one patient to another.

A stage label helps the team describe the disease and plan treatment. It does not, by itself, decide whether surgery is possible or predict exactly how one person will respond.

What operation might I need?

Cytoreductive surgery (CRS) aims to remove all visible cancer that can be removed safely. Many patients and families know CRS as “debulking surgery.” In advanced ovarian cancer, the operation may involve more than removing the uterus, ovaries and fallopian tubes. Depending on where disease is found, surgery may include removal of the omentum and selected tumour deposits from the peritoneum, diaphragm surface, bowel or other involved areas.

The planned operation should be explained before consent, including procedures that may become necessary if cancer involves nearby organs. The extent is individual. A list of possible procedures does not mean every patient will need all of them.

Why does the surgeon try to remove all visible cancer?

The surgical goal is usually complete macroscopic cytoreduction, meaning no visible disease remains at the end of the operation. Evidence reviewed by the US National Cancer Institute identifies residual disease after surgery as an important outcome factor. The team must balance this goal against the safety and likely benefit of a major operation.

“Optimal debulking” and “complete cytoreduction” are related terms but are not always used in exactly the same way. Ask the surgeon which term is being used and what result the team believes is realistically achievable.

Should I have surgery first or chemotherapy first?

There are two common treatment sequences for newly diagnosed advanced epithelial ovarian cancer.

Primary cytoreductive surgery (primary CRS)

Surgery is performed first, followed by chemotherapy. This may be considered when scans and specialist assessment suggest complete removal is achievable with an acceptable surgical risk.

Neoadjuvant chemotherapy followed by interval surgery

Chemotherapy is given first, commonly for a limited number of cycles. The team then reassesses the response and whether interval cytoreductive surgery (interval CRS) is appropriate. Chemotherapy-first treatment may be considered when the disease pattern makes complete surgery unlikely at the outset, when the expected operation would carry excessive risk, or when a patient needs medical optimisation before major surgery.

Randomised evidence summarised by the NCI supports chemotherapy followed by interval surgery as an established option for selected patients with Stage IIIC or IV disease. This does not mean one sequence is automatically better for everyone. Selection matters.

How will my team decide whether surgery should come first?

The decision normally combines several pieces of information:

CT or other imaging showing the distribution of disease
biopsy or cytology confirming the cancer type
CA-125 and other relevant blood tests
nutrition, strength, heart and lung health, and other medical conditions
symptoms such as bowel obstruction, abdominal fluid or breathing difficulty
the likelihood that visible cancer can be removed safely
the expected complexity of surgery and available specialist support
the patient’s priorities and informed preference

Some centres use diagnostic laparoscopy or structured imaging assessment when resectability is uncertain. The exact approach varies.

What chemotherapy might I receive?

Platinum-based chemotherapy is a central part of treatment for advanced epithelial ovarian cancer. Carboplatin with a taxane such as paclitaxel is commonly used, but the exact medicines, doses and schedule depend on the pathology, fitness, previous reactions and treatment plan.

After initial treatment, molecular and genetic test results may affect maintenance-treatment discussions. BRCA1/BRCA2 and homologous-recombination-related testing can be relevant, but suitability for targeted treatment must be discussed with the oncology team.

Will I need HIPEC during surgery?

HIPEC is heated chemotherapy delivered inside the abdomen during selected cytoreductive operations. It is not automatically suitable for every patient with Stage III ovarian cancer. Its role depends on the timing of surgery, disease pattern, prior treatment, fitness and the treating centre’s protocol. Read more about HIPEC surgery, then ask whether it is relevant to your situation.

How difficult is the operation and recovery?

Cytoreductive surgery (CRS) can be a major operation. Risks depend on the procedures required and may include bleeding, infection, blood clots, chest complications, bowel or urinary problems, wound problems, a temporary or permanent stoma, and the need for intensive monitoring. Your surgeon should explain the risks that apply to the proposed operation.

Recovery may involve pain control, prevention of blood clots, breathing and walking exercises, nutrition support, and gradual return of bowel function and daily activity. Ask who to contact for fever, worsening abdominal pain, vomiting, shortness of breath, wound changes or inability to eat or drink.

How long might I need help at home?

The amount of help needed depends on the size of the operation, complications and how quickly strength, eating and bowel function return. In the early period, a family member may help with meals, medicines, appointments, short walks and noticing warning signs. The treating team should give an individual plan rather than promise a fixed recovery time.

Family members should seek advice if the patient develops fever, repeated vomiting, worsening abdominal pain, breathing difficulty, wound discharge, confusion, cannot drink, or becomes much less active. Ask before discharge whom to call during the day and outside clinic hours.

Questions to ask before deciding

Is the diagnosis confirmed as high-grade serous carcinoma?
What does my scan show about where the cancer has spread?
Does the team recommend surgery first or chemotherapy first, and why?
How likely is complete visible tumour removal?
Which organs might need treatment or removal during surgery?
Could I need bowel surgery or a stoma?
What are the important risks in my case?
How will treatment affect nutrition, mobility and daily activity?
Has my case been discussed by a multidisciplinary team?
Do I need tumour and inherited genetic testing?
Is a second opinion useful before starting treatment?

What to bring to a specialist consultation

Bring your pathology or biopsy report, slides or blocks if requested, CT/MRI/PET reports and image files, CA-125 and other blood-test results, discharge summaries, a list of medicines and medical conditions, and details of previous surgery or chemotherapy. A written list of questions can help you understand the goal and sequence of treatment.

If you want another review before a major decision, request a gynaecological-cancer second opinion. You can also read the main ovarian cancer guide and learn about Dr Nishtha Tripathi Patel.

Frequently asked questions

Is Stage IIIC ovarian cancer operable?

Many patients with Stage IIIC disease have surgery, but operability cannot be decided from the stage alone. The team considers disease distribution, possibility of complete removal, surgical risk, general health and likely benefit.

Does chemotherapy before surgery mean the cancer is inoperable?

No. Neoadjuvant chemotherapy followed by interval surgery is an established sequence for selected patients. It may improve the chance of a safer, more effective operation or be used because surgery first is unlikely to achieve the intended result.

Will all reproductive organs always be removed?

Advanced high-grade serous ovarian cancer usually requires treatment that does not preserve fertility, but the exact operation depends on disease extent and previous surgery. Patients who have not completed their family should raise fertility and menopause concerns before treatment begins, even when options may be limited.

Is robotic or laparoscopic surgery used for Stage IIIC ovarian cancer?

Extensive cytoreduction is commonly performed through open surgery because several abdominal areas may need treatment. Minimally invasive surgery may have a role in assessment or carefully selected situations, but it should not compromise the cancer operation. The surgical route must be chosen for oncological safety and the planned extent of surgery.

Should I get a second opinion?

A second opinion can be useful when the recommended sequence is unclear, surgery may be extensive, resectability is uncertain, or you want confirmation before starting chemotherapy or undergoing a major operation.

Medical references

Medical information on this page is general education and does not replace assessment by your treating team.

Book a consultation to discuss your reports, treatment sequence and surgical questions.